Mercury Grosvenor Trust PLC
17 December 1999
The issuer has made the following amendment to the 'Performance at Month End'
announcement released on 6 December 1999 at 12:50 under RNS No 0099C.
All of the % Portfolio figures in the bottom two tables were incorrect and have
been changed.
The full corrected version is shown below.
-------------------------------------------------------------------------------
MERCURY GROSVENOR TRUST plc
All information is at 30th November 1999 and unaudited
Performance at month end with net income reinvested
Three One Three Five
Months year years years
Net asset value 2.8% 17.7% 57.9% 154.7%
Share price 1.5% 29.5% 62.5% 120.1%
FTSE All-Share Index 5.5% 20.5% 68.9% 135.7%
At month end
Net asset value: 328.13p includes current yr net income of 8.44p
Share price: 266.00p Discount: 18.9%
Total assets: £85.09m Net yield: 1.9%
Gearing: 0.0% Value of debt: Nil
Ordinary shares in issue: 25,933,170
The NAV is recalculated monthly with respect to cash, cash
equivalents and quoted investments in the portfolio.
Unquoted investments were last revalued at 30th June 1999
UK Sector % Portfolio
Support Services 24.1
Health 22.1
Property 9.5
Overseas Venture Funds 7.8
Pharmaceuticals 4.8
Distribution 4.7
Media 3.5
Engineering 1.9
Electronics 1.5
Paper, Packaging & Printing 1.2
Hotels & Leisure 1.2
Telecom 1.1
Cash/Fixed Interest 16.6
-----
100.0
Ten Largest Investments
Company % Portfolio Sector
G2 Estates 9.5 Property
Tunstall 8.0 Health
PII 6.9 Support Services
Priory Healthcare 5.9 Health
Braitrim 5.7 Support Services
Weston Presidio 4.5 Overseas Funds
Dechra Holdings 4.4 Distribution
Biocompatibles+ 3.7 Health
Patientline Holdings 3.4 Support Services
Match 3.1 Health
----
55.1
====
+ Listed on The London Stock Exchange
Sources: Mercury Asset Management Ltd, Micropal
Latest information is available by typing 'MAMINDEX' on Reuters, 'MAMI' on
Bloomberg, or '8800' on Topic3 (ICV terminal).
16th December 1999.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.